A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation

Thrombosis Research

Volumn 129, Issue 6, 2012, Pages 693-699

  Mahé, Isabelle ^a,b   Bergmann, Jean François ^c   Chassany, Olivier ^d   Dit Sollier, Claire Bal ^a,c   Simoneau, Guy ^c   Drouet, Ludovic ^a,c  

^a CREATIF Centre de Référence des Antithrombotiques Ile de France   (France)

^b HÔPITAL LOUIS MOURIER   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Atrial fibrillation; cardiovascular events; D dimer

Indexed keywords

ANTICOAGULANT AGENT; D DIMER;

AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIAC PATIENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861337992     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.08.014     Document Type: Article

References (29)

1. European Heart Rhythm Association European Association for Cardio-Thoracic Surgery A.J. Camm, P. Kirchhof, G.Y. Lip, and U. Schotten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
2. D.E. Singer, Y. Chang, M.C. Fang, L.H. Borowsky, N.K. Pomernacki, and N. Udaltsova The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
3. D.E. Singer, G.W. Albers, J.E. Dalen, M.C. Fang, A.S. Go, and J.L. Halperin Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 8th Edition Chest 133(6 Suppl.) 2008 546S 592S
4. Antithrombotic therapy in atrial fibrillation American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl. 2008 546S 592S
5. ACTIVE Writing Group of the ACTIVE Investigators S. Connolly, J. Pogue, R. Hart, M. Pfeffer, and S. Hohnloser Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
6. ACTIVE Investigators S.J. Connolly, J. Pogue, R.G. Hart, S.H. Hohnloser, and M. Pfeffer Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
7. M.A. Crandall, B.D. Horne, J.D. Day, J.L. Anderson, J.B. Muhlestein, and B.G. Crandall Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors Pacing Clin Electrophysiol 32 2009 981 986
8. M.C. Fang, A.S. Go, Y. Chang, L. Borowsky, N.K. Pomernacki, and D.E. Singer Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815
9. G.Y.H. Lip, and G.D.O. Lowe Fibrin D-dimer: a useful clinical marker of thrombogenesis Clin Sci 89 1995 205 214
10. G.Y.H. Lip, P.L. Lip, J. Zarifis, R.D. Watson, D. Baregord, and G. Lowe Fibrin D-dimers and -thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin Circulation 94 1996 425 431
11. I. Mahé, L. Drouet, G. Simoneau, S. Minh-Muzeaux, C. Caulin, and J.F. Bergmann D-dimer can predict survival in patients with chronic atrial fibrillation Blood Coagul Fibrinolysis 15 2004 413 417
12. U.N. Ibebuogu, A.K. Salah, S. Malhotra, J.B. Calkins Jr., J.W. Thornton III, and M. Mandawat The D-dimer assay: a possible tool in the evaluation of atrial thrombosis Can J Cardiol 24 2008 517 519
13. A. Cohen, S. Ederhy, C. Meuleman, E. Di Angelantonio, G. Dufaitre, and F. Boccara D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism? Eur Heart J 28 2007 2179 2180
14. G.D. Lowe Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture Br J Haematol 133 2006 232 250
15. T. Sadanaga, M. Sadanaga, and S. Ogawa Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy J Am Coll Cardiol 55 2010 2225 2231
16. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
17. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513
18. P.L. Harper, E. Theakston, J. Ahmed, and P. Ockelford D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderly Intern Med J 37 2007 607 613
19. C.F. Pieper, K.M. Rao, M.S. Currie, T.B. Harris, and H.J. Chen Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons J Gerontol A Biol Sci Med Sci 55 2000 M649 M657
20. F.L. Li-Saw-Hee, A.D. Blann, and G.Y. Lip Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation Stroke 31 2000 828 833
21. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
22. I. Mahé, L. Drouet, and O. Chassany D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation Thromb Res 107 2002 1 6
23. K. Ohara, H. Inoue, T. Nozawa, T. Hirai, A. Iwasa, and K. Okumura Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation Int J Cardiol 126 2008 316 321
24. H. Inoue, T. Nozawa, K. Okumura, L. Jong-Dae, A. Shimizu, and K. Yano Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism Chest 126 2004 687 692
25. N. Vene, A. Mavri, K. Kosmelj, and M. Stegnar High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy Thromb Haemost 90 2003 1163 1172
26. T. Nozawa, H. Inoue, T. Hirai, A. Iwasa, K. Okumura, and J.D. Lee D-dimer level influences thromboembolic events in patients with atrial fibrillation Int J Cardiol 109 2006 59 65
27. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 1992 242 250
28. Stroke Risk in Atrial Fibrillation Working Group Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation Stroke 39 2008 1901 1910
29. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, and A. Parekh RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151